Skip to Content

ClearBridge All Cap Value C SFVCX

Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 10.99  /  +1.10 %
  • Total Assets 1.5 Bil
  • Adj. Expense Ratio
    1.830%
  • Expense Ratio 1.830%
  • Distribution Fee Level Above Average
  • Share Class Type Level Load
  • Category Large Value
  • Investment Style Mid Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.59%
  • Turnover 24%

USD | NAV as of Feb 22, 2024 | 1-Day Return as of Feb 22, 2024, 11:17 PM GMT+0

Morningstar’s Analysis SFVCX

Will SFVCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in ClearBridge All Cap Value C's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SFVCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 24.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Wells Fargo & Co

2.96 44.3 Mil
Financial Services

American International Group Inc

2.72 40.7 Mil
Financial Services

UnitedHealth Group Inc

2.46 36.9 Mil
Healthcare

Fiserv Inc

2.44 36.5 Mil
Technology

AbbVie Inc

2.38 35.6 Mil
Healthcare

Vistra Corp

2.32 34.7 Mil
Utilities

Micron Technology Inc

2.28 34.1 Mil
Technology

Noble Corp PLC Class A

2.25 33.7 Mil
Energy

Freeport-McMoRan Inc

2.13 31.9 Mil
Basic Materials

Johnson & Johnson

2.09 31.3 Mil
Healthcare